Arnold Bullock, MD
Urology · Saint Louis, MONPI 1992721120
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Boston Scientific at 53.5% of the total. Reporting peaked in 2019 at $5,297 and has fallen 67.9% since, to $1,703 in 2025. Among urology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 352 payments — averaging $54.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Coloplast$4K
- Neotract Inc.$1K
- Teleflex LLC$970
- Astellas Pharma US Inc$599
- Calyxo, Inc.$408
- plus $2K from 28 others
What the payments were for
- Consulting fees$4002%
- Travel & lodging$7,29438%
- Food & beverage$11,06757%
- Education$5793%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 204 | $10,345 |
| Coloplast | 37 | $3,851 |
| Neotract Inc. | 23 | $1,126 |
| Teleflex LLC | 12 | $970 |
| Astellas Pharma US Inc | 12 | $599 |
| Calyxo, Inc. | 4 | $408 |
| Janssen Scientific Affairs, LLC | 2 | $246 |
| Procept Biorobotics Corporation | 5 | $220 |
| Cook Medical LLC | 2 | $189 |
| Antares Pharma, Inc. | 2 | $175 |
| ABC Home Medical Supply, Inc. | 5 | $158 |
| Bayer | 5 | $124 |
| Innovation Technologies Inc | 1 | $95 |
| Convatec Inc. | 3 | $93 |
| Sumitomo Pharma America, Inc. | 5 | $80 |
| Pfizer | 4 | $76 |
| 180 Medical, Inc. | 3 | $69 |
| Hollister Incorporated | 1 | $62 |
| Polynovo North America LLC | 2 | $54 |
| Axogen | 2 | $51 |
| AbbVie(2 entities) | 3 | $49 |
| Novartis | 2 | $35 |
| Astellas Pharma Global Development | 1 | $32 |
| Acera Surgical, Inc. | 1 | $32 |
| Progenics Pharmaceuticals, Inc. | 1 | $29 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| Laborie Medical Technologies Corp. | 2 | $25 |
| Merck | 1 | $24 |
| KCI USA, Inc. | 1 | $20 |
| Intuitive Surgical | 1 | $20 |
| Tolmar, Inc. | 1 | $18 |
| Zimmer Biomet | 1 | $18 |
| Ambu Inc. | 1 | $13 |
| Avadel Specialty Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TITAN$3,189
- AMS 700 CXR RTE KIT$2,104
- GENERAL ERECTILE DYSFUNCTION$1,339
- UroLift$671
- UroLift System$662
- AMS$330
- CVAC Aspiration System$284
- Erleada$246
- Barrigel$192
- Cook$173
- MYRBETRIQ$125
- XYOSTED$125
- PENILE & TESTICULAR RECONSTRUCTN$120
- GENERAL PAIN MANAGEMENT$119
- AMS 700$115
How this compares
$19,340 in reported general payments places this provider in the 90th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 18 | $12,452 |
| MyrbetriqMirabegron | 20 | $12,446 |
| Tolterodine Tartrate ErTolterodine Tartrate | 147 | $10,126 |
| Solifenacin Succinate | 69 | $3,366 |
| Finasteride | 211 | $1,761 |
| Tamsulosin Hcl | 165 | $1,563 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 16 | $970 |
| Bicalutamide | 13 | $375 |
| Sildenafil Citrate | 71 | $297 |
| Oxybutynin Chloride | 30 | $267 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 50 | $225 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 48 | $181 |
| Ciprofloxacin Hcl | 22 | $124 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 18 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $80 | $12,45218 claims |
| Astellas Pharma US IncMyrbetriq | $599 | $12,44620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 250 urology providers in Missouri.
Other urology in Saint Louis
- Travis BullockSaint Louis$201K
- Michael JohnsonSaint Louis$160K
- Gurdarshan SandhuSaint Louis$101K
- Gregory McLennanSaint Louis$89K
- Gerald AndrioleSaint Louis$64K
- Charles JonesSaint Louis$55K
- Meredith MetcalfSaint Louis$26K
- Maung Htein ThuSaint Louis$22K
- Alexander ChowSaint Louis$20K
- Jonathan WeeseSaint Louis$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.